False-Positive Circulating Tumor DNA Results Do Not Explain Lack of Efficacy for PARP Inhibitors in Patients With Castration-Resistant Prostate Cancer Harboring ATM and CHEK2 Mutations.
JCO Precis Oncol
; 8: e2400354, 2024 Aug.
Article
in En
| MEDLINE
| ID: mdl-39208375
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms, Castration-Resistant
/
Ataxia Telangiectasia Mutated Proteins
/
Checkpoint Kinase 2
/
Poly(ADP-ribose) Polymerase Inhibitors
/
Circulating Tumor DNA
/
Mutation
Limits:
Aged
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
JCO Precis Oncol
Year:
2024
Document type:
Article